1. ALLA AKTIER
  2. NYHETER
  3. BACTIGUARD

Bactiguard

Nyheter Bactiguard Nyheter alla bolag
Affiliate
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

New number of shares and votes in Bactiguard Holding AB

LHFI

The number of shares and votes in Bactiguard Holding AB (publ) (the “Company”) has increased during July 2026 as a result of the new issue of Class C shares to secure the Company’s commitments under the share-based long-term incentive plan 2026 (“LTIP 2026”). All Class C shares have been repurchased by the Company and will be converted into Class B shares in connection with the delivery of Class B shares to participants under the terms of LTIP 2026.

As of 31 July 2026, the number of shares in the Company amounts to 35,758,885, of which 4,000,000 are Class A shares carrying 10 votes per share, 31,043,885 are Class B shares carrying 1 vote per share and 715,000 are Class C shares carrying 1 vote per share. The total number of votes in the Company amounts to 71,758,885. The total number of votes in the Company, excluding the Company’s own holding of 715,000 Class C shares, amounts to 71,043,885.

For further information, please contact:
Patrick Bach, CFO +46 761 295 911

About Bactiguard
Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas where infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access.

Bactiguard operates through license partnerships with leading global MedTech companies that apply the technology to their medical devices. The company also has a portfolio of wound management products. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine. Bactiguard is headquartered in Stockholm and is listed on Nasdaq Stockholm and is included in the Small-Cap segment.

Read more about Bactiguard: www.bactiguard.com
Follow Bactiguard on LinkedIn

This information is information that Bactiguard Holding is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2026-07-31 07:00 CEST.

Attachments
New number of shares and votes in Bactiguard Holding AB

Datum 2026-07-31, kl 07:00
Källa MFN
Bifogade filer
New number of shares and votes in Bactiguard Holding AB